Therapy: Targeting chromatin remodelling proteins to treat pancreatic cancer.

Nature reviews. Gastroenterology & hepatology ·Vol. 12 ·No. 11 ·2015-11-00 ·Pages 608

Thomas H

Abstract

暂无摘要

MeSH Terms

Adenocarcinoma/drug therapy Animals Carcinoma, Pancreatic Ductal/drug therapy Epigenesis, Genetic Histone Deacetylase Inhibitors/therapeutic use Humans Proteins/antagonists & inhibitors

Chemicals

Histone Deacetylase Inhibitors Proteins

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Thomas Hugh

References (1)

1 references, click to expand

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Nat Med. 2015 Oct;21(10):1163-71 PMID: 26390243

Article Info

Journal

Nature reviews. Gastroenterology & hepatology

Abbr.

Nat Rev Gastroenterol Hepatol

ISSN

1759-5053

DOI

10.1038/nrgastro.2015.171

Published

2015-11-00

Epub

2015-00-06

Pages

608

Language

English

Region

England

NLM ID

101500079

Subset

Corrections

CommentOn

PMID: 26390243

External Links

PubMed source DOI: 10.1038/nrgastro.2015.171 View journal details

Analysis Services

Therapy: Targeting chromatin remodelling proteins to treat pancreatic cancer.

Contact

WeChat Official Account